|
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. (300401.SZ) Valation DCF |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401.SZ) Bundle
Explorez les perspectives financières de Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. (300401SZ) à l'aide de notre calculatrice DCF conviviale! Entrez vos projections pour la croissance, les marges et les dépenses pour calculer la valeur intrinsèque de Zhejiang Garden Biochimical High-Tech Co., Ltd. (300401SZ) et affinez votre approche d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 614.9 | 1,117.1 | 1,417.5 | 1,094.7 | 1,243.3 | 1,552.1 | 1,937.7 | 2,419.1 | 3,020.0 | 3,770.2 |
| Revenue Growth, % | 0 | 81.67 | 26.89 | -22.78 | 13.58 | 24.84 | 24.84 | 24.84 | 24.84 | 24.84 |
| EBITDA | 350.5 | 645.0 | 525.9 | 383.1 | 550.2 | 717.4 | 895.6 | 1,118.1 | 1,395.8 | 1,742.6 |
| EBITDA, % | 57.01 | 57.73 | 37.1 | 35 | 44.25 | 46.22 | 46.22 | 46.22 | 46.22 | 46.22 |
| Depreciation | 45.7 | 44.6 | 61.0 | 133.4 | 155.8 | 125.5 | 156.7 | 195.6 | 244.2 | 304.9 |
| Depreciation, % | 7.43 | 3.99 | 4.3 | 12.18 | 12.53 | 8.09 | 8.09 | 8.09 | 8.09 | 8.09 |
| EBIT | 304.9 | 600.4 | 464.9 | 249.8 | 394.3 | 591.9 | 738.9 | 922.4 | 1,151.6 | 1,437.6 |
| EBIT, % | 49.58 | 53.74 | 32.8 | 22.82 | 31.72 | 38.13 | 38.13 | 38.13 | 38.13 | 38.13 |
| Total Cash | 1,358.7 | 502.5 | 554.9 | 1,502.9 | 1,424.7 | 1,192.4 | 1,488.7 | 1,858.5 | 2,320.2 | 2,896.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 70.1 | 90.5 | 169.7 | 92.8 | 158.4 | 163.5 | 204.2 | 254.9 | 318.2 | 397.2 |
| Account Receivables, % | 11.4 | 8.1 | 11.97 | 8.48 | 12.74 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 |
| Inventories | 306.8 | 429.0 | 545.9 | 780.0 | 838.2 | 824.1 | 1,028.9 | 1,284.5 | 1,603.5 | 2,001.9 |
| Inventories, % | 49.89 | 38.4 | 38.51 | 71.26 | 67.42 | 53.1 | 53.1 | 53.1 | 53.1 | 53.1 |
| Accounts Payable | 158.6 | 329.6 | 265.2 | 327.9 | 340.5 | 407.7 | 509.0 | 635.5 | 793.4 | 990.5 |
| Accounts Payable, % | 25.8 | 29.5 | 18.71 | 29.95 | 27.39 | 26.27 | 26.27 | 26.27 | 26.27 | 26.27 |
| Capital Expenditure | -578.5 | -707.4 | -379.9 | -244.6 | -480.4 | -761.1 | -950.2 | -1,186.2 | -1,480.9 | -1,848.8 |
| Capital Expenditure, % | -94.08 | -63.32 | -26.8 | -22.34 | -38.64 | -49.04 | -49.04 | -49.04 | -49.04 | -49.04 |
| Tax Rate, % | 13.79 | 13.79 | 13.79 | 13.79 | 13.79 | 13.79 | 13.79 | 13.79 | 13.79 | 13.79 |
| EBITAT | 254.8 | 496.7 | 403.2 | 227.6 | 339.9 | 509.4 | 636.0 | 794.0 | 991.2 | 1,237.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -496.3 | -137.7 | -176.3 | 21.9 | -95.8 | -50.0 | -301.6 | -376.5 | -470.0 | -586.8 |
| WACC, % | 5.61 | 5.6 | 5.63 | 5.65 | 5.62 | 5.62 | 5.62 | 5.62 | 5.62 | 5.62 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,461.1 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | -607 | |||||||||
| Terminal Value | -28,616 | |||||||||
| Present Terminal Value | -21,768 | |||||||||
| Enterprise Value | -23,230 | |||||||||
| Net Debt | 233 | |||||||||
| Equity Value | -23,462 | |||||||||
| Diluted Shares Outstanding, MM | 595 | |||||||||
| Equity Value Per Share | -39.46 |
What You Will Receive
- Accurate (300401SZ) Financials: Access historical and projected data for precise valuation.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Automated Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Zhejiang Garden's potential future performance.
- User-Friendly Design: Designed for professionals, yet easy for beginners to navigate.
Key Features
- Comprehensive Financial Data: Gain access to precise historical records and forecasts for Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401SZ).
- Flexible Forecast Customization: Modify the highlighted cells for WACC, growth rates, and profit margins to suit your analysis.
- Automated Calculations: Enjoy real-time updates for DCF, Net Present Value (NPV), and cash flow evaluations.
- User-Friendly Dashboard: Utilize easy-to-interpret charts and summaries to represent your valuation findings.
- Designed for All Skill Levels: A straightforward and intuitive setup created for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the prebuilt Excel template featuring data on Zhejiang Garden Bio-chemical High-tech Co., Ltd. ([300401SZ]).
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the key performance indicators.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins) as needed.
- Step 4: Instantly access recalculated results, including the intrinsic value of Zhejiang Garden Bio-chemical High-tech Co., Ltd. ([300401SZ]).
- Step 5: Utilize the outputs to make well-informed investment decisions or create detailed reports.
Why Opt for This Calculator?
- Designed for Experts: A sophisticated tool favored by analysts, CFOs, and consultants.
- Accurate Data: Zhejiang Garden Bio-chemical's historical and projected financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a seamless experience.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and dependable valuation models for analyzing portfolios, specifically for Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401SZ).
- Corporate Finance Teams: Evaluate valuation scenarios to shape internal strategies related to Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401SZ).
- Consultants and Advisors: Equip clients with precise valuation insights for shares of Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401SZ).
- Students and Educators: Utilize real-time data to practice and teach financial modeling with a focus on Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401SZ).
- Biotech Enthusiasts: Gain insights into how biotech firms like Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401SZ) are assessed in the market.
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401SZ), including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A specialized sheet for calculating the Weighted Average Cost of Capital (WACC), featuring parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that illustrate intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to aid in analysis.
- Key Ratios: Includes ratios related to profitability, leverage, and efficiency for Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401SZ).
- Dashboard and Charts: A visual summary of valuation outputs and assumptions for straightforward result analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.